Impact of Real-time MIC (Minimum Inhibitory Concentration) Reporting (<6 Hours) on β-lactam Prescription in Cases of Gram-negative Bacilli Bacteremia in ICU Patients in Real-life Settings

NANot yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Gram-negative BacteremiaIntensive Care Patients
Interventions
DIAGNOSTIC_TEST

SPECIFIC REVEAL® Rapid AST system

The SPECIFIC REVEAL™ system uses biosensors capable of detecting volatile substances released by microorganisms during their growth. The detection of these volatile compounds by ultra-high-performance biosensors enables very early detection of bacterial growth compared with standard technologies based on visual systems (e.g. diffusion antibiogram or MICs determined by microdilution in liquid media) or optical density measurement systems (e.g. Vitek2)

DIAGNOSTIC_TEST

antibiotic susceptibility testing on agar medium

Performance of an antibiotic susceptibility test on agar medium, with results expected between H18 and H24

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT07202377 - Impact of Real-time MIC (Minimum Inhibitory Concentration) Reporting (<6 Hours) on β-lactam Prescription in Cases of Gram-negative Bacilli Bacteremia in ICU Patients in Real-life Settings | Biotech Hunter | Biotech Hunter